
EMA delays Valneva vaccine approval
The CHMP’s action puts pressure on the French-Austrian vaccine developer, which wanted to market the vaccine from April on as the UK has already...

Mimetas BV participating in €325m cancer funding
As part of a financing of the Dutch Naional Growth Fund the Oncode-PACT (Preclinical Accelerator for Cancer Treatments) initiative has been granted...

Precirix NV raises €80m in Series B financing
The Series B financing round was led by led new investors INKEF Capital, Jeito Capital and Forbion. “The investment will allow Precirix to accelerate...

Argenx SE to raise €637m
Last December, the Breda-based drugmaker got the green lightfrom the US FDA for its injectible anti-acetylcholin receptor antibody fragment...

Bavarian Nordic bags $225m for licence to RSV vaccine
Under the terms of the agreement, Bavarian Nordic A/S (Copenhagen) will receive an upfront payment of US$12.5m and potential milestone payments of up...
Commission to establish EU health data space
The EU Commission is set to present a draft law on a "European health data area" this Tuesday, which could be a big thing for digital...

Bayer Leaps to invests €1.3bn externally
"We are on the threshold of a new era of innovation in the life sciences." commented Werner Baumann, Chairman of the Board at Bayer...